A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, ...

Men with a family history of prostate cancer should begin screenings at age 40 or even earlier, especially if multiple close relatives have been affected. Research consistently indicates that African ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

What makes prostate cancer screening different than other cancer types? Get the facts. Test your knowledge of 5 factors of prostate cancer screening and shared decision-making. Shared decision-making ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...

Prostate cancer was the second leading cause of cancer deaths in North Carolina men in 2021; the bill aims to lower those rates.

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

A new at-home saliva test could easily help identify men with a high risk of prostate cancer more accurately than blood tests ...